H1B Report
Side-by-side comparison

COGNIZANT TECHNOLOGY SOLUTIONS US CORP vs Mayo Clinic

A direct H-1B sponsorship comparison built from the same DOL Labor Condition Application data that drives every page on H1B Report. Total filings, outcome rates, top occupations and yearly demand side-by-side.

Entity A
COGNIZANT TECHNOLOGY SOLUTIONS US CORP
TXRank #2FEIN 13-3924155
Entity B
Mayo Clinic
MNRank #96FEIN 41-6011702

Key metrics

All percentages are share of total LCAs filed by each sponsor.

MetricCOGNIZANT TECHNOLOGY SOLUTIONS US CORPMayo Clinic
Total filings128,8524,398
Certified %96.13%96.11%
Denied %0.28%1.07%
Withdrawn %2.23%2.66%
Cert-withdrawn %1.36%0.16%
Rank#2#96
Active yearsFY2010–FY2026FY2011–FY2026
Worksite stateTXMN

Outcomes — COGNIZANT TECHNOLOGY SOLUTIONS US CORP

DOL case-status mix.

Outcome breakdown: Certified 96.1%, Cert-withdrawn 1.4%, Withdrawn 2.2%, Denied 0.3%
Outcome breakdown
OutcomeShare
Certified96.1%
Cert-withdrawn1.4%
Withdrawn2.2%
Denied0.3%
Certified96.1%
Cert-withdrawn1.4%
Withdrawn2.2%
Denied0.3%

Outcomes — Mayo Clinic

DOL case-status mix.

Outcome breakdown: Certified 96.1%, Cert-withdrawn 0.2%, Withdrawn 2.7%, Denied 1.1%
Outcome breakdown
OutcomeShare
Certified96.1%
Cert-withdrawn0.2%
Withdrawn2.7%
Denied1.1%
Certified96.1%
Cert-withdrawn0.2%
Withdrawn2.7%
Denied1.1%

Yearly filing volume

Year-over-year H-1B demand for each sponsor.

COGNIZANT TECHNOLOGY SOLUTIONS US CORP
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20101,476
FY20112,735
FY20121,772
FY20131,557
FY20142,189
FY20153,112
FY20164,612
FY20172,384
FY201812,460
FY201925,569
FY20203,117
FY202110,079
FY202213,705
FY202315,729
FY202411,437
FY202511,140
FY20265,779
Mayo Clinic
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20100
FY2011244
FY2012264
FY2013299
FY2014318
FY2015304
FY2016306
FY2017373
FY2018369
FY2019359
FY202016
FY202115
FY20226
FY2023112
FY2024462
FY2025582
FY2026369

Top 5 occupations — COGNIZANT TECHNOLOGY SOLUTIONS US CORP

Swap an entity
Replace either sponsor above without losing the comparison. 2-way for now; 3+ comparison coming soon.